You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Concurrent antituberculosis therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Incorporating Biometric Data for Patients Receiving Concurrent

Not yet recruiting
  • Cancer
    • Wilmington, North Carolina
      Novant Health Cancer Institute Radiation Oncology
    Jul 7, 2023

    Peyronie Disease, Erectile Dysfunction Trial in Rochester (Collagenase Clostridium Histolyticum, Storz Duolith LiSWT)

    Not yet recruiting
    • Peyronie Disease
    • Erectile Dysfunction
    • Collagenase Clostridium Histolyticum
    • Storz Duolith LiSWT
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    Sep 26, 2023

    Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined

    Not yet recruiting
    • Lung Neoplasms
    • Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
    • Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
    • (no location specified)
    Jun 12, 2023

    Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

    Enrolling by invitation
    • Esophageal Carcinoma
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Sep 19, 2023

    NSCLC Trial in Jinan (TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation, TQB2450 injection, sequential

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation
    • TQB2450 injection, sequential or concurrent chemoradiation
    • Jinan, Shandong, China
      Cancer Hospital Affiliated to Shandong First Medical University
    May 5, 2023

    Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab

    Not yet recruiting
    • Localized Muscle Invasive Bladder Urothelial Carcinoma
    • Muscle-Invasive Bladder Carcinoma
    • Sacituzumab govitecan
    • Adaptive Radiotherapy
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Apr 18, 2023

    Esophageal Squamous Cell Carcinoma Trial (AK104)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Oct 25, 2022

    Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
    • +4 more
    • Guangzhou, Guangdong, China
      SUN Yat-sen University Cancer Center
    Sep 11, 2023

    MDD Trial run by the National Institute of Mental Health (NIMH) (Sham TMS + Cognitive therapy, Active TMS + Cognitive therapy)

    Recruiting
    • Major Depressive Disorder
    • Sham TMS + Cognitive therapy
    • Active TMS + Cognitive therapy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 29, 2022

    Stage III NSCLC Trial in Guangzhou (Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy)

    Recruiting
    • Stage III Non-small Cell Lung Cancer
    • Neoadjuvant chemo-immunotherapy
    • +5 more
    • Guangzhou, China
      Sun Yat-sen University
    Jul 19, 2022

    Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)

    Recruiting
    • Lymphoma
    • Radiation Therapy
    • +5 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 9, 2022

    Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Feb 18, 2023

    Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

    Recruiting
    • Stage III Non-small-cell Lung Cancer
    • Neoadjuvant therapy
    • +4 more
    • Foshan, Guangdong, China
    • +2 more
    Oct 25, 2022

    Concurrent Paclitaxel and Radiotherapy After Adjuvant

    Not yet recruiting
    • Breast Cancer
    • Concurrent chemoradiation
    • (no location specified)
    Oct 16, 2022

    Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • Beijing, Beijing, China
      Department of Radiation Oncology, Cancer Institute and Hospital,
    Jul 12, 2023

    Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

    Recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • Intensity-modulated radiotherapy concurrent with capecitabine
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer center
    Aug 21, 2022

    Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

    Not yet recruiting
    • Muscle-Invasive Bladder Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Aug 3, 2023

    Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

    Not yet recruiting
    • Muscle Invasive Bladder Urothelial Carcinoma
    • Daily Adaptive External Beam Radiation Therapy
    • Saint Louis, Missouri
      Washington University, St. Louis
    Jan 17, 2023

    Cervical Cancer Trial in Chongqing (salvage surgery)

    Recruiting
    • Cervical Cancer
    • salvage surgery
    • Chongqing, Chongqing, China
      Chongqing Cancer Hospital
    Feb 20, 2023

    Study to Evaluate Effects of Concurrent Therapy of Sarpogrelate

    Completed
    • Arteriosclerosis Obliterans
    • Busan, Korea, Republic of
      BuKyung Kim
    Nov 14, 2022

    Prostate Cancer, Lower Urinary Tract Symptoms Trial in Kansas City (Holmium Laser Enucleation of Prostate (HoLEP))

    Recruiting
    • Prostate Cancer
    • Lower Urinary Tract Symptoms
    • Holmium Laser Enucleation of Prostate (HoLEP)
    • Kansas City, Kansas
      University of Kansas Health System
    Nov 15, 2022

    Cervical Cancer, Stage IIB Trial in Mexico City (Placebo dairy beverage)

    Completed
    • Cervical Cancer, Stage IIB
    • Placebo dairy beverage
    • Mexico City, Tlalpan, Mexico
      National Cancer Institute of Mexico
    Feb 16, 2023

    Mycosis Fungoides Trial in Houston (Brentuximab vedotin)

    Recruiting
    • Mycosis Fungoides
    • Brentuximab vedotin
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 14, 2022

    Contributing Factors for Poor HIV Treatment Response in TB/HIV

    Recruiting
    • Tuberculosis
    • +2 more
    • Observational study
    • Kumasi, Ghana
      Kwame Nkrumah University of Science and Technology
    Mar 23, 2022

    Nasopharyngeal Carcinoma, TNF, Chemo-radiotherapy Trial (5-fu, Cisplatin, Radiotherapy)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • +2 more
    • (no location specified)
    Jun 22, 2022